Ventana Medical Systems' (Ventana) CONFIRM anti-CD99 (O13) Mouse Monoclonal Primary Antibody (CONFIRM anti-CD99 (O13)) is directed against human CD99 expressed on T lymphocytes, cortical thymocytes, granulosa cells of the ovary, pancreatic islet cells, CNS ependymal cells and Sertoli’s cells. CD99 shows a plasma membrane location. This antibody may be used as part of a panel to aid in the identification of Ewing’s sarcoma and related peripheral neuroectodermal tumors. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.
This antibody is intended for in vitro diagnostic (IVD) use.